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ABSTRACT 
Background: Cancer patients have been documented to use complementary and 
alternative medicine (CAM) frequently, a subject that has been extensively researched.  
There is however a lack in the current literature of controlled studies that investigate the 
prevalence of CAM use among cancer patients compared to non-cancer controls.   
Aim: To assess and compare the prevalence of dietary related CAM use among adult 
cancer patients and non-cancer controls in the Norwich area, England. 
Methods: Self-administered questionnaires were used to survey cancer patients 
attending a comprehensive cancer centre in Norwich, and non-cancer controls attending 
three dental surgeries also in the Norwich area. Questions addressed patient 
demographics, information relating to cancer diagnosis (cancer cases only) and 
information on CAM use. CAM users were asked about types and duration of CAM use, 
reasons for use, information sources used, disclosure to health professionals, reported 
side effects and benefits and satisfaction with CAM therapies. 
Results: Questionnaires were distributed to 132 cancer cases and 126 controls, with 98 
and 96 assessable replies received from the cases and controls respectively. Overall, 
47% of the cancer cases used CAM, in comparison to 53% of the control group, with no 
significant difference (p=0.673) between the two groups. Large quantities of juice, 
multivitamins, fish oils and glucosamine were the most popular CAM therapies among 
the two groups. Usage was significantly associated with the cancer site (p=0.036) and 
duration of cancer diagnosis (p=0.050). Only 54% of the cancer cases and 44% of the 
controls informed a health professional about their CAM use. The main reasons for 
using CAM were to boost the immune system and to improve quality of life. Reported 
benefits included increased optimism and hope.  
Conclusions: Although CAM was commonly used by British cancer patients, there was 
no significant difference in comparison to the non-cancer controls. Therefore, increased 
awareness and knowledge of CAM use should not be limited only to those working with 
oncology patients, but be extended to health professionals in all patient groups. 
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OPSOMMING 
Agtergrond: Daar is gedokumenteer dat kankerpasiente dikwels Komplementêre en 
Alternatiewe Medisyne (KAM) gebruik, en dit is al intensief nagevors.  Daar is egter ’n 
gebrek aan gekontroleerde studies wat die prevalense van KAM verbruik in 
kankerpasiënte en nie-kanker kontroles vergelyk. 
Doelstelling: Om die prevalensie van dieetverwante KAM onder kanker pasiënte en 
nie-kanker kontroles in die Norwich area, Engeland te bepaal. 
 Metodes: Selfvoltooide vraelyste is gebruik om kankerpasiënte wat ‘n omvattende 
kankereenheid in Norwich besoek na te vors, asook nie-kanker kontroles wat drie 
verskillende tandartspraktyke in die Norwich omgewing besoek het. Vrae het pasiënt 
demografie, kanker diagnose (slegs kankergevalle) en inligting in verband met KAM 
gedek. KAM verbruikers is gevra oor die tipe en tydperk van die verbruik van KAM, 
redes vir  verbruik, bronne van inligting, meedeling aan gesondheidswerkers, newe-
effekte en voordele, asook tevredenheid met KAM terapieë.  
Resultate: Vraelyste is uitgegee aan 132 kankergevalle en 126 kontroles, waarvan 98  
en 96 verwerkbare vraelyste van die gevalle en kontroles onderskeidelik teruggekry is.     
Sewe-en-veertig  persent van die kankergevalle het KAM gebruik, in vergelyking met 
53% van die kontrolegroep, met geen betekenisvole verskil (p=0.673)  tussen die twee 
groepe nie.  Groot hoeveelhede sap, multivitamiene, visolies en glukosamien was die 
gewildste KAM in die twee groepe.  Verbruik is betekenisvol geassosieerd met kanker 
diagnose (p=0.036) en duurte van diagnose (p=0.050). Slegs 54% van die 
kankergevalle en 44% van die kontroles het ‘n gesondheidswerker ingelig van hul 
gerbuik van KAM terapieë.  Hoofredes vir die gebruik van KAM was om die 
immuunsisteem en kwaliteit van lewe te verbeter. Voordele het groter optimisme en 
hoop ingesluit. 
Gevolgtrekking: Alhoewel KAM algemeen deur Britse kanker pasiënte gebruik word, 
was daar geen beduidende verskil in vergelyking met die nie-kanker kontroles nie.  Dus 
moet ‘n verhoogde bewustheid en kennis van KAM nie beperk word tot diegene wat met 
kanker pasiënte werk nie, maar dit moet ook uitgebrei word na gesondheidswerkers in 
ander pasiëntgroepe. 
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1.1 Introduction 
Cancer patients have been documented to use complementary and alternative 
medicine (CAM) frequently, but the usage rate varies widely between countries and 
is based on varying definitions of CAM.1,2 The increased interest in CAM among 
cancer patients may be due to limitations of conventional cancer treatment, 
increased media coverage of CAM, or the desire for holistic or natural treatments. It 
may also be used as a last resort when conventional treatment has failed. As cancer 
incidence increases, and survival time lengthens, the population seeking information 
about and access to CAM is likely to increase.3  
1.2  Definition of CAM 
It is necessary to distinguish between complementary and alternative medicine, 
despite the acronymic term commonly used. 
Complementary therapies are used as adjuncts to mainstream cancer care and are 
supportive measures that control symptoms, enhance well-being and contribute to 
overall patient care. On the other hand, alternative therapies are typically promoted 
for use instead of mainstream treatment.4 It is important to note that while these 
therapies are used widely, often without supervision, CAM may potentially be either 
beneficial or detrimental to a person’s health. It is thus essential that the health 
professional has sufficient knowledge to advise patients regarding these therapies or 
practices. 
1.3  Prevalence of CAM Use – the Trend Worldwide 
The use of CAM is increasing worldwide. A national survey in the United States 
demonstrated an increase in use from 33.8% to 42.1% between 1990 and 1997.5  In 
a systematic review by Ernest and Cassileth in 1998, 21 studies included adult 
cancer patients from 13 countries.6  Fifty per cent of these studies reported that up to 
27% of respondents used CAM; the remaining studies found that more than 25% of 
respondents had tried CAM therapies. Percentages ranged from a low of 7% to a 
high of 64%. The average percentage use across adult studies was 31.4%. 
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CAM therapies are also popular among patients with chronic diseases other than 
cancer.  Noiesen et al. (2007) has done a survey on Danish patients with allergenic 
contact dermatitis and found that 40% of the subjects used CAM, predominantly in 
combination with conventional treatment.7 Another study was conducted by Hilsden 
et al. (2003) on Canadian patients with inflammatory bowel disease and it was 
reported that 47% of the subjects in this study used CAM.8 However, no studies 
could be found where the use of CAM in cancer patients was compared to other 
diseases. 
1.4 Prevalence in Britain 
Fewer studies on the prevalence of CAM use were found in the United Kingdom.  
Downer et al. (1994) found that 16% of cancer patients used complementary 
therapies of which the most popular included healing, relaxation, visualization, diet, 
homeopathy, vitamins, herbalism and the Bristol approach9 (see pages 4 and 7 for 
further reference). 
A recent study of women with breast cancer (n=714) in the South Thames NHS 
region of the UK found that 22% of participants had consulted a CAM practitioner, 
and 33% had purchased CAM products over the counter in the previous 12 
months.10   Another recent study by Harris et al. (2003) found that 49.6% of oncology 
patients had used at least one type of CAM in the previous 12 months at the time the 
study was conducted.11 Usage was more frequently reported for 
aromatherapy/massage therapy, relaxation and vitamins/minerals or fish/vegetable 
extracts.  
1.5 Demographics of Patients Using CAM 
Virtually all studies conducted to date in cancer patients and of the general public 
internationally show that those patients who seek CAM tend to be better educated, of 
higher socio-economic status, female, married or living with a partner and younger 
than those that do not use CAM.4, 12, 13   Younger patients may be more likely to use 
CAM as they are more mobile than older people, and therefore have greater access 
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to complementary services.  They may also be more motivated to take extra steps 
(i.e. CAM services) to try and regain health.  Additionally younger patients may be 
more likely to have prior experience acting assertively in relation to systems of 
authority, due to societal changes over the past several decades.14  Patients of 
higher socio-economic status may also be more likely to use CAM, as they have 
more resources for additional services.14 Similarly, many married patients or those 
living with a partner have a second income for the household and could therefore 
also have more resources available for additional services such as CAM. 
1.6 Different Types of CAM Used 
1.6.1 Diets commonly used among cancer patients 
More than 40 different cancer diets have been claimed to prevent and/or treat 
cancer. These diets typically emphasize avoiding meat, and many are strictly 
vegetarian.15  Current examples include the Macrobiotic diet, the Bristol diet and the 
Gerson diet.9,15  The Macrobiotic diet is based on the belief that cancer is caused by 
an imbalance of yin and yang.  It is assumed that imbalances can be corrected by 
eating foods with either yin or yang qualities.  The macrobiotic diet is composed 
primarily of wholegrain products (50 – 60%) and fresh vegetables (20 -40%).  Meat 
and milk are not allowed, but small amounts of fish are permitted.  Macrobiotic diets 
allow few fluids but they require large amounts of salt intake (about 30g/day).15 It is, 
however, an expensive diet to follow as it requires special foods, tapes, literature, 
seminars, workshops and counseling.16 The range of food choices are limited, 
placing people following this diet at risk for significant nutritional deficiencies.4 To 
date there is no clinical evidence to suggest that this diet prevents, alleviates or 
cures cancer.15, 16, 17      
The Bristol diet, developed at Penny Brohn Cancer Care (formerly Bristol Cancer 
Help Centre), is a type of complementary diet therapy. It is perhaps the best-known 
diet in the UK for people with cancer. The emphasis of this diet is on wholefoods; 
fresh fruit and vegetables; raw cereals; and organic fish, poultry and eggs. The diet 
stresses the avoidance of dairy produce such as milk, cheese and yoghurt, red meat, 
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salt, sugar and caffeine (e.g. tea and coffee) and encourages the use of organically 
grown produce.17 Although the Bristol diet can be nutritionally sound, nutritional 
deficiencies can occur if food choices are too restricted.  This may also be an 
expensive diet to follow as it requires all food to be organically produced. However, 
no published literature could be found on the possible consequences of this regime.   
The Gerson diet is a vegan diet and a form of alternative medicine, and patients are 
expected to consume the juices of about 9kg of fruit and vegetables per day 
(primarily carrots and apples).  The diet is often supplemented with coffee enemas.  
The “Gerson Institute” offers anecdotal evidence of success in its promotional 
literature.  However, the study referred to was retrospective, its sample size was 
small, and about a third of the patients were lost to follow up.  Bias was further 
introduced by use of a self-selected sample, and through the use of non-randomised 
controls.15,16,17 No study published in the peer-reviewed literature provides 
reasonable evidence that the Gerson therapy is effective in the treatment of cancer. 
However, serious infections and death from electrolyte imbalance due to the use of 
coffee enemas have been reported.16 
1.6.2 Micronutrient supplementation 
Megavitamin therapy is characterized by the use of large doses of one or more 
vitamins, and its use as an adjunct to current cancer therapies is continuously being 
explored. Many oncologists have long maintained that high dose adjunctive 
antioxidant vitamins are contra-indicated in patients undergoing either radiotherapy 
or chemotherapy, because antioxidants might reduce tumor cell kill effects by 
interfering with treatment induced tumoricidal free radical production. However, there 
is an increasing amount of data indicating that high doses of vitamin supplementation 
in combination with conventional therapy, may increase tumor response and improve 
quality of life by decreasing the toxicity of conventional treatment.18, 19 In fact, a 
recent review of the literature by Simone et al. which included 280 peer-reviewed in 
vitro and in vivo studies, have consistently shown that antioxidants and other 
micronutrients such as β-carotene (10 000–20 000IU), Vitamin A (9 000–40 000 IU), 
Vitamin C (500-5000mg) and  Vitamin E (200 -2500 IU), selenium (387µg); Vitamin 
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D3 (0.75mg), Vitamin K3 (as menadione 1-3 g/m2) and glutathione (200–2500mg) as 
single agents or in combination) do not interfere with therapeutic modalities for 
cancer.  It also showed that these nutrients may enhance the destructive potential of 
therapeutic modalities for cancer, decrease their side-effects and protect normal 
tissue. 20  Of concern, however, is the findings of an increased risk of lung cancer 
associated with supplementation with β-carotene. A large primary prevention trial 
(The Beta-Carotene and Retinol Efficacy Trial) involving supplementation with 30mg 
of β-carotene plus 25 000 IU of retinol, was terminated ahead of schedule during 
early 1996 after preliminary results showed a 28% increase in lung cancer and a 
17% increase in overall deaths in the supplemented group.21 
 
1.6.3 Herbal medicinal products (HMPs) 
With many medicinal plants it is not possible to define the principle active 
constituents; the clinical effects of most HMPs are produced by more than one active 
compound, and in many instances the full range has not been identified. Several 
traditions of herbal medicine (e.g. traditional Chinese medicine, Aurveda) typically 
use complex, often individualized, mixtures of several medicinal herbs in one single 
prescription, although most modern self-prescribed HMPs consist of one single 
herb.12 Few products have been formally tested for side effects or quality control 
(Table 1.1).4  
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Table 1.1:  Examples of medicinal products for which systematic reviews and meta-
analysis have been published 12 
Common name or plant Indication Evidence of effectiveness 
Aloe vera Various Poor 
Artichoke Hyperlipoptroteinemia Poor 
Feverfew Prevention of migraine Encouraging 
Ginger Nausea and vomiting Encouraging 
Ginkgo biloba Dementia Good 
Ginkgo biloba Intermittent claudication Good 
Ginkgo biloba Tinnitus Good 
Ginseng Various Poor 
Horse chestnut Chronic venous insufficiency Good 
Kava Anxiety Very good 
Mistletoe Cancer Poor 
Peppermint Irritable bowel syndrome Encouraging 
St John’s wort Mild/Moderate depression Very good 
Valerian Insomnia Encouraging 
 
1.6.4 Homeopathy 
Homeopathy is a therapeutic method using diluted preparations or substances 
whose effects, when administered to healthy subjects, correspond to the 
manifestations of the disorder (symptoms, clinical signs, pathological states) in the 
individual patient.17, 22 The body’s own healing process is believed to be stimulated 
by these highly diluted substances derived from plants, minerals or animals. 
Efficiency is unlikely to be due to the extreme dilution of the active ingredient in 
homeopathy.4  Systematic reviews and meta-analysis of homeopathy clinical trials 
show no definite proof that these remedies are effective for any medical condition.22  
1.6.5 Shark cartilage 
Advocates of shark cartilage as a cancer therapy base their therapy on its putative 
antiangiogenic properties.4 Two glycoproteins have been isolated from the cartilage 
of the hammerhead shark and were reported to have strong antiangiogenic activity 
inhibiting tumour neovascularization, an effect which could be helpful in human 
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cancer therapy. However, as macromolecules are not usually absorbed by the 
intestinal tract, it is questionable whether these glycoproteins ever reach the 
bloodstream in sufficiently high concentrations. To date, no controlled clinical studies 
testing the efficacy of shark cartilage have been published.15 
1.6.6 Coffee enemas 
As part of the Gerson diet, coffee enemas are usually administered on a four-hourly 
basis to help relieve pain, nausea and other symptoms accompanying detoxification. 
Proponents claim that caffeine is absorbed in the colon, leading to vasodilatation of 
the liver, which in turn enhances the process of elimination of toxins. The 
assumptions are unproven, and there is no reliable evidence of the clinical efficiency 
of coffee enemas for any indication.15, 16 
1.6.7 Other non-dietary related CAM 
Other non-dietary CAM includes acupuncture, chiropractic therapy, meditation, 
ozone therapy and spiritual healing.  Acupunture is the insertion of needles to 
stimulate acupuncture points located along meridians, which are assumed to 
promote the flow of Qi (life force), thereby restoring the balance needed for 
health.15,17 There is good evidence for the use of acupuncture for non-specific back 
pain, dental pain, migraine and nausea/vomiting. Of these conditions, only nausea 
and vomiting are directly relevant to cancer patients. Chiropractic therapy is based 
on the belief that the nervous system is the most important determinant of a person’s 
state of health.  Chiropractors employ spinal manipulation to treat symptoms such as 
neck and back pain. However, there is no evidence that chiropractic alleviates 
symptoms related specifically to cancer.15 Meditation is a general term describing 
treatments in which a person empties his/her mind of extraneous thought with the 
elevating mind to a different level and transcending in mundane concerns.15,17  The 
physiological effects of meditation are those of deep relaxation. There is evidence 
from controlled clinical trials suggesting that these effects can be used to control 
cardiovascular risk factors, chronic pain and anxiety, which could be of benefit to 
cancer patients.15 Ozone therapy is a treatment promoted for cancer, and includes 
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drawing up to 300ml of blood, expose it to a mixture of oxygen and ozone, followed 
by a reinfusion of this blood into the patient. Numerous reports exist of serious 
complications, including hepatitis and at least five fatalities have been reported.15  
Spiritual healing has been defined as the direct interaction between one individual 
(the healer) and a patient, with the intention of improving the patient’s condition or 
curing the illness.  Treatment can occur through personal contact or through a 
distance.  Several variations exist, including therapeutic touch, Reiki (placing of 
hands over certain parts of the body to rechannel energy flow and reversing  
illness17), faith healing and intercessory prayer. Mind-body interventions such as 
meditation, relaxation, self-hypnosis and yoga are considered beneficial and sound 
supportive care.15 Good documentation exists for these therapies in stress reduction, 
symptom management, and control of some physiological reactions. 15, 23  
1.7 Perceived Benefits and Reasons for Using CAM 
As more cancer patients turn to CAM in their quest to find a cure for their illness or to 
better their quality of life, the need to understand their views or perceptions of CAM is 
of interest. 24  Various studies have reported that reasons for using CAM include pain 
relief, relaxation, enhancing treatment outcome and to help cope with the side effects 
of conventional medical treatment.11,13 Other reasons include that cancer patients 
value the closer relationships possible with CAM practitioners, and because they 
want more control over, and greater responsibility for, self-care.4 Another study 
showed that the three most important reasons for using CAM included the desire to 
include every available option (77%), having information that CAM had worked well 
for others (70%) and feeling that CAM was less harmful or more natural than 
conventional treatment.25  
In the study by Harris et al., dissatisfaction with CAM was low, although one in four 
patients was uncertain about the benefit of diet/supplements.11     
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1.8 Known Drug Interactions of CAM and Toxicity/Safety  
The general public tends not to be aware that herbs are dilute drugs that contain 
scores of different chemicals, most of which have not been documented. Their 
effects are not always predictable.4 In addition, in this unregulated industry, it is 
extremely difficult to guard against consumer fraud.26 The potential for harm is 
considerable for several of the CAM treatments (e.g. coffee enemas, ozone therapy, 
HMPs).15 Patients undergoing active treatment should be advised to stop using 
herbal remedies, because some herbs cause problematic interactions with 
chemotherapeutic agents, sensitizations of the skin to radiation therapy, dangerous 
blood pressure swings, and other unwanted interactions with anaesthetics during 
surgery (Table 1.2). Herbs such as feverfew, garlic, ginger and ginkgo have 
anticoagulant effects and should be avoided by patients on coumadin, heparin, 
aspirin and related agents.4, 26 St John’s Wort is a readily available over the counter 
herb that is commonly used to treat depression. Side effects include nausea and 
hypersensitivity reactions which can decrease dietary intake in an already 
nutritionally compromised patient.26 In high doses Echinacea can lead to 
hypersensitivity reactions including anaphylaxis; whereas green tea can lead to side 
effects such as emesis, insomnia, diarrhoea and confusion.26 Concerns have been 
raised recently about dietary antioxidants, which may interact with radiation therapy 
or chemotherapeutic agents.4 The risk of herb-drug interactions appears to be 
greatest for patients with kidney or liver function impairment.4 Unfortunately there is 
currently essentially no regulation by any governmental body, including the FDA, on 
the safety or effectiveness of herbal medications.4, 15, 26  
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Table 1.2  Toxicity of commonly used complementary and alternative medicine (CAM) 26  
CAM Toxicity 
St John’s Wort Nausea, hypersensitive reactions 
Ephedra alkaloids Hypertension, tachycardia, stroke, seizures 
Kava Yellow discolorization of skin/nails, hepatic dysfunction, stupor, visual 
disturbances, dizziness 
Echinacea Hypersensitivity reactions (including anaphylaxis) 
Saw palmetto Diarrhea, constipation, head ache, hypertension, insomnia, nausea 
Ginseng Diarrhea, headache, hypertension, insomnia, nausea 
Gingko Emesis, headache 
Green Tea Emesis, insomnia, diarrhea, confusion 
Hydrazine sulfate Hepato-renal failure 
Shark cartilage Emesis, constipation, hepatitis 
Laetrile Emesis, headache, dizziness, obtundation, dermatitis 
Antineoplasms Somnolence, confusion 
 
 
1.9 Reporting of CAM Use to Physicians 
Patients appear increasingly willing to discuss the use of CAM therapies, especially 
when asked by their oncologist.4 In fact one study showed that the majority of 
subjects would welcome the opportunity to talk to their physicians about their use of 
these therapies.13 A study on women with breast cancer found that 73.8% of 
participants had communicated use of CAM therapies to their physicians,12 however, 
another study on various types of malignancies found that only 41% of CAM users 
had informed their oncologist. Older patients were significantly less likely to inform 
oncologists than younger patients.28 
1.10 Patient Expectations Regarding the Use of CAM 
Several studies found that cancer patients were using CAM in the hope of anti-
cancer effects, some were hoping for a cure and others for control or prevention of 
the spread of the cancer. 9, 27  Some expected that CAM would boost the immune 
system.7 CAM use in general is not supported by convincing data.15  This is 
particularly true for CAM as a cancer cure.  The role of CAM as a palliative or 
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supportive cancer treatment might be slightly different.  CAM modalities such as 
acupuncture and reflexology have the potential to increase well-being with little 
potential for harm 15  Furthermore, certain antioxidants such as vitamin E and vitamin 
C  may also be of benefit for cancer patients undergoing chemotherapy (by reducing 
the generation of lipid peroxides resulting from the chemotherapy) and are relatively 
safe to use at high doses. Antioxidants may also have an important role in patients 
undergoing radiotherapy by selectively inhibiting repair of radiation damage of cancer 
cells, whilst protecting normal tissue. The doses at which such positive effects were 
noticed, ranged from  200 to 2500 IU of Vitamin E per day and 500mg to 5000mg 
Vitamin C per day.19,20,29  
1.11 Motivation for this Study  
To date most studies reported a high use of CAM in cancer patients. However, a 
major limitation of these studies is that they were not controlled; hence we do not 
know how cancer patients compare with other groups.  It is important to assess 
whether oncology patients are more likely than the general public to use CAM as 
they are often already nutritionally compromised, and certain type of CAM use may 
further restrict dietary intake. To date there is only one controlled study that we are 
aware of where the use of CAM in cancer survivors was compared with a non-
cancer population.30 According to their findings CAM use was modestly higher 
among cancer survivors (40%) compared to the general population (36%).   
 
In addition, is it important for the health professional working in oncology to have an 
idea of the types of CAM most commonly used in their area and their reasons for 
using CAM.  This will improve patient care and enable the health care professional to 
advise on safe and beneficial CAM practice in a patient-centered environment.   
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2.1 Aim of the Study 
The aim of the study was to assess and compare the prevalence of dietary related 
complementary and alternative medicine (CAM) use among adult cancer patients at the 
Colney Cancer Centre and non-cancer controls, Norwich area, England. 
 
2.2 Objectives  
2.2.1  To identify the most common CAM used, with a special reference to diet, 
micronutrients and herbs. 
2.2.2 To determine the correlation between CAM use and patient characteristics.  
2.2.3 To determine how often patients discuss the use of CAM with health 
professionals. 
2.2.4 To determine patient’s reasons for CAM use. 
2.2.5 To investigate reported perceived side effects/complications of CAM use. 
2.2.6 To determine the perceived benefits and satisfaction of CAM use. 
 
2.3 Null Hypothesis 
There is no significant difference in dietary related CAM use between cancer patients 
and non-cancer controls. 
 
2.4 Study Design 
An analytical, cross-sectional study design was used. Data were collected by means of 
structured validated questionnaires. A quantitative approach was used throughout the 
data collection process. 
 
2.5 Subjects 
 
2.5.1 Description of the Study population  
 
The cancer cases in this study consisted of all adult cancer outpatients attending the 
Colney Cancer Centre at the Norfolk and Norwich University Hospital between mid 
November and end of November 2006. Being the only comprehensive cancer centre in 
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the Norwich area offering chemotherapy, radiotherapy and surgery, the Colney Cancer 
Centre drains patients from a mixture of socio-economic backgrounds.  Although the 
majority of patients attending the Colney Cancer Centre are NHS (National Health 
Service) patients, private patients also make use of the centre’s specialist treatments.  
 
Since cancer patients, who are usually older than the general population, often present 
with co-morbid chronic conditions such as hypertension, it was decided to use a control 
group with similar co-morbities instead of using healthy controls (i.e. comparable in all 
aspects other than cancer). This would allow for the assessment of the effect of cancer 
per se on the use of CAM.  The investigators therefore decided not to select the controls 
from Norfolk and Norwich Hospital since such patients would generally be suffering from 
illness, resulting in a control group with a higher burden of chronic disease compared to 
the cancer group.  The controls were therefore recruited from dental surgeries in the 
area who are visited by a better mix of healthy people and those suffering from chronic 
disease. The controls consisted of all adult non-cancer patients waiting in the reception 
areas of a convenience sample of three pre-selected dental surgeries between mid 
January and end of January 2007.  In order to allow for a range of socio-economic 
backgrounds, it was decided to include two NHS dental surgeries and one private dental 
surgery.  Two of the surgeries were located in Norwich’s city centre (1 NHS and 1 
private), while the third surgery (NHS) was in Attleborough, a small rural town within the 
immediate surroundings of Norwich.  The chosen dental surgeries were:  
 
1.  Orford Hill Dental Surgery (NHS), Norwich  
2.  Corner House Dental Surgery (Private), Norwich  
3.  Church Street Dental Surgery (NHS), Attleborough  
 
2.5.2 Sample size  
To determine the sample size required for the study, the average number of patients 
that attended the Colney Cancer Centre during the period of April 2004 until March 2005 
was calculated at 1944 patients.  This information was provided by the Information 
Technology Department of the hospital and included the total number of patients 
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(excluding follow-up appointments) of all the different oncology and haematology out-
patient clinics, as well as those who came for chemotherapy and radiotherapy 
treatments. A sample size of 92 cancer patients (cases) was calculated to achieve a 
10% precision at a 95% confidence interval. This level of precision was considered 
acceptable to allow for a tolerable burden for participants in a fragile oncology setting, as 
was requested by the Norfolk Research Ethics Committee. The controls were to be of 
similar size and matched for age and gender.  It was decided not to match the controls 
for ethnicity, as only 6% of the Norwich population consists of ethnic minorities (of which 
3% is non-white) and should therefore not have a significant impact on the results.31 
Furthermore, it would have complicated the matching process, as two other variables 
were already being matched for.  
 
2.5.3 Inclusion criteria 
2.5.3.1 Cancer cases 
Any diagnosis of cancer was included among cases. 
Patients had to be English speaking and at least 18 years of age. 
Patients had to be able to read and write English. 
 
2.5.3.2 Non-cancer controls 
Subjects had to be English speaking and at least 18 years of age. 
Subjects had to be able to read and write English. 
 
2.5.4 Exclusion criteria 
2.5.4.1 Cancer cases 
Patients not willing to participate in the study. 
Patients younger than 18 years of age. 
Patients that took part in the pilot study. 
 
2.5.4.2 Non-cancer controls 
Patients not willing to participate in the study. 
Patients younger than 18 years of age. 
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Patients with cancer  
Patients that formed part of the pilot study 
 
2.6 Methods of Data Collection 
2.6.1 Selection of cases and controls 
2.6.1.1 Cancer cases          
Data collection of the cancer cases took place from mid November until the end of 
November 2006. This arm of the study was conducted twice a week over a period of 
three weeks.  It was agreed with the out-patients manager to limit data collection to only 
twice a week, as there were issues with understaffing, which resulted in long queues at 
the reception desk where data collection was taking place.  All the oncology out-patients 
share the same waiting room and reports to the main reception desk. To maximise the 
likelihood that all tumour sites were included, clinics from each day of the week (each 
weekday represent specific tumour related clinics) were included in equal proportions 
over the three week period as follows:  week one included the Monday and Wednesday 
clinics; week 2 included the Tuesday and Thursday clinics, and week 3 included the 
Friday clinics. Posters were displayed in the waiting area of the Colney Cancer Centre to 
inform patients of the study in progress. Systematic sampling was used, whereby the 
volunteer asked every third patient if they would like to participate in the study as they 
reported to the receptionist. For logistical reasons it was decided to use systematic 
sampling (as opposed to randomised sampling), in order to cause minimum disruption to 
an already understaffed and overcrowded reception area. A letter explaining the 
purpose of the study and assuring confidentiality (addendum 1) was offered to patients 
at the same time, together with an anonymous questionnaire (addendum 2). Consent 
was assumed if a patient agreed to take part in the study, which is standard practice in 
the case of anonymous self-administered questionnaires where participants complete 
the questionnaire themselves and in their own time.  The volunteer was available for 
assistance if patients had any questions related to the content of the questionnaire. The 
researcher was also available in case the volunteer was unable to answer their 
questions.  
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2.6.1.2 Non-cancer controls 
Data collection of the non-cancer controls took place from mid January until the end of 
January 2007. It was conducted on a daily basis as opposed to the cancer cases where 
data collection was conducted twice a week only.  The reason for these differences in 
sampling between the two groups was that different weekdays were not linked to 
specific types of patient groups as was the case with the cancer cases. In terms of 
record keeping, each dental surgery was provided with a table of how many subjects in 
each age category needed to be included, to allow for matching according to age and 
gender. Posters were displayed in the waiting areas to inform subjects of the study in 
progress. The reception staff identified the patients that were suitable to be included in 
the study according to their age and gender, and invited them to participate in the study. 
A letter explaining the purpose of the study and assuring confidentiality (addendum 3) 
together with an adapted anonymous self-administered questionnaire (addendum 4) 
were offered at the same time.  As patients needed to be matched with the cancer 
cases, it was not possible to select every third patient that reported to the receptionist, 
as was the case with the cancer cases. Selection of the controls was discontinued once 
the required numbers in each age and gender category were obtained.  Although there 
is a slight possibility of introducing bias, it is unlikely that these differences in sampling 
would have a major impact on the results. 
 
2.6.2 Questionnaire  
Self-administered anonymous questionnaires which were compiled by the researcher 
were used to obtain the required data in the cancer cases, and a similar questionnaire, 
which was adapted to be suitable for the non-cancer population, was used for the 
controls.  The questionnaire was based on those used in previous CAM studies 2, 25, 27, 
28, 45 which included CAM types most commonly identified in previous studies, reasons 
for CAM use, notification of health professionals and CAM information sources. 
However, additional sections relating specifically to diet and nutrition were added (such 
as dietary changes as a result of cancer, specific micronutrients, and impact on weight). 
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The content of the questionnaire was validated by a panel of experts (see section 
2.6.2.4).  
 
The following information was obtained:  
 
2.6.2.1 Demographic information: 
• Age 
• Gender 
• Marital status 
• Level of education 
• Annual household income 
 
2.6.2.2 Information relating to diagnosis  
• Type of cancer – tumour site (cases only) 
• Time since diagnosis of cancer (cases only) 
• Type of treatment e.g. chemotherapy, radiotherapy or hormonal treatment 
(cases only).  
• Other diseases present e.g. diabetes or hypertension. 
 
2.6.2.3 Information on CAM use 
• Type of CAM use 
• Reasons for CAM use 
• When CAM was used 
• CAM information sources 
• Disclosure of CAM use to health professionals 
• Reported side effects and benefits  
• Satisfaction with CAM use 
  
2.6.2.4 Questionnaire validity 
In order to ensure content validity of the questionnaires, the input of a panel with clinical 
and research experience in the field of oncology and the use of CAM therapies among 
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cancer patients was obtained. The panel consisted of a professor (MD, PhD, FRCP and 
FRCP (Edin)) from the Department of Complementary Medicine at the Peninsula 
Medical School in Exeter, a senior lecturer (AFBPsS, MRSS) in Psychology at the 
University of Wales with an interest in CAM research and a consultant oncology dietitian 
(PhD) from the Royal Marsden Hospital (London). Recommendations from the panel 
were mostly related to the manner of phrasing and wording of questions, rather than its 
content. All recommendations were considered and the questionnaire adjusted 
accordingly.  
Face validity was evaluated by means of a pilot study of ten subjects to assess to what 
extent the questionnaire was understood by subjects. Five subjects were cancer 
patients, and the other five were non-cancer patients. Both groups consisted of a 
convenience sample where the receptionists identified subjects who meet the selection 
criteria to participate in the study. The pilot study for the cancer cases took place in the 
Colney Cancer Centre on 25th of October 2006, and the healthy controls in Church 
Street Dental Practice (Attleborough) on 5th of November 2006. These ten subjects 
included both gender groups, a variety of age groups, tumour sites, and cancer 
treatments and were excluded from the final study population. All ambiguous questions 
identified during the pilot study were subsequently rephrased and clarified according to 
the responses and suggestions received by the pilot study participants. These changes 
related to the wording and phrasing of questions, rather than the content of the 
questionnaire. 
2.6.3 Data collection 
To increase accuracy, all participants recorded their responses directly onto the 
questionnaire. Completed questionnaires were collected by the researcher for coding 
and analysis at the end of data collection. A daily record was kept including the amount 
of questionnaires handed out at each session, how many were returned on the day, and 
how many questionnaires were taken home by participants with the intention of 
completing it at home. Prepaid addressed envelopes were handed out to those 
participants who chose to complete the questionnaires at home. A record was kept of 
the number of participants who declined to take part in the study.  The researcher 
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checked the questionnaires for completeness before it was entered into the Excel 
Spreadsheet.  Questionnaires of which only the demographic data were completed were 
excluded from the study (cancer cases: n=3; non-cancer controls: n=3) Questionnaires 
that were completed by patients not eligible to participate in the study were also 
excluded (cancer cases: n=1; non-cancer controls: n=1).   All other questionnaires were 
included for analysis. 
 
2.7 Ethical Issues 
The study obtained ethics approval from the Institutional Review Boards of the 
University of Stellenbosch (project number: N05/10/178), the East Norfolk and Waveney 
Research Governance Committee (reference number: 2005DIET01S) and the Norfolk 
(1) Research Ethics Committee (REC Reference number: 06/Q0101/65). Confidentiality 
of the study population was maintained by the use of anonymous self-administered 
questionnaires. Patients received a covering letter together with the questionnaire, 
explaining the purpose of the study, the right to withdraw, what is expected of them, 
potential benefits / risks, anonymity and confidentiality of information, as well as contact 
details of the investigator.  Consent was assumed if a participant completed and 
returned the questionnaire.  They were not asked to give explanations if they declined to 
participate in the study and were allowed to withdraw at any time.  
2.8 Analysis of Data 
The researcher carried out data management by entering the data obtained from the 
questionnaires into an Excel spreadsheet. Data analysis was performed with the help of 
a statistician, using Statistica 7 software.  
 
Descriptive statistics were obtained to summarise the means and standard deviations of 
each variable. Graphs were generated to show the relationship between different 
variables. To determine whether the data acquired was consistent with a normal 
distribution, histograms, box plots, Q-Q plots and mean/median values were used to 
ensure most of the data conformed to a normal distribution. Due to the large number of 
variables, it was expected that a few of the variables may not be normally distributed. 
Non-parametric statistics were used where this was not the case. 
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Homogeneity of variances was considered, before independent sample T-tests were 
undertaken, whilst Mann-Whitney tests were done when data was not normally 
distributed. To test whether there was a statistically significant difference between the 
two groups of nominal variables, Chi-square tests were used.  
 
The following data were obtained and analysed: 
• Frequency of CAM use among both cancer patients and controls 
• The association between CAM use in cancer patients and demographic 
characteristics   
• The most common form of CAM used 
• The prevalence of reporting CAM use to health professionals 
• The reasons for CAM use 
• The perceived side effects/complications of CAM use 
• Any differences in the prevalence of CAM use between cancer patients and controls. 
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CHAPTER 3: RESULTS REPORTING 
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3.1 Data Collection 
3.1.1 Cancer cases 
Anonymous questionnaires were offered to a total of 132 cancer patients of which 102 
were returned. This gave a response rate of 77.3%. Sixteen patients declined to take 
part in the study, and 14 of the questionnaires that were handed out were not returned. 
Of the 102 returned questionnaires, 98 were suitable for analysis. Among the four 
questionnaires that were not suitable for analysis, one patient did not have cancer, and 
was therefore excluded. Only the section on demographic information was completed on 
the remaining three questionnaires and these questionnaires were also excluded from 
the study. 
 
3.1.2 Non-cancer controls  
Anonymous questionnaires were offered to a total of 126 patients of which 96 
questionnaires were returned. This gave a response rate of 76.2%. Eleven patients 
declined to take part in the study, and 19 questionnaires that were handed out, were not 
returned. Of the 96 returned questionnaires, 92 were suitable for analysis. Among the 
four questionnaires that were not suitable for analysis and therefore excluded, one 
patient had a diagnosis of cancer, and the remaining three only answered the questions 
relating to demographic information. 
 
3.2 Demographic and Diagnosis Related Characteristics 
Overall, the cancer cases and the non-cancer controls compared well in terms of their 
socio-demographic profiles, with no significant differences (p > 0.05) in any of the 
variables referred to in Table 3.1.  
The majority of the study population consisted of older people with an average age of 
62.7 years [Standard Deviation (SD) 10.9) for the cancer cases and 59.7 years (SD 
12.9) for the non-cancer controls. Sixty-three percent of the cancer cases and 56% of 
the non-cancer controls were over the age of 60 at the time of the study. More women 
than men participated in the study with women accounting for 59% of the cancer cases 
and 63% of the non-cancer controls. The majority of participants in both groups were 
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married or lived with a partner (81% of the cancer cases and 68% of the non-cancer 
controls respectively).   
Table 3.1: Respondents’ demographic data  
Variable Cancer Cases (n=98)  
Number (%) 
Non-cancer Controls (n=92)  
Number (%) 
Age in years (chi-square test: p=0.437)  
18 – 29 0 (0%) 3 (3%) 
30 – 39 1 (1%) 1 (1%) 
40 – 49 12 (12%) 11 (12%) 
50 – 59 23 (23%) 26 (28%) 
60 – 69 35 (36%) 29 (32%) 
70 – 79 21 (21%) 19 (21%) 
80 – 89 6 (6%) 3 (3%) 
Gender (chi-square test: p=0.586) 
Male 40 (41%) 34 (37%) 
Female 58 (59%) 58 (63%) 
Marital Status (chi-square test: p=0.056) 
Single 8 (8%) 2 (2%) 
Married/living together 79 (81%) 63 (68%) 
Divorced/Seperated 4 (4%) 8 (9%) 
Widowed 7 (7%) 19 (21%) 
Education (chi-square test: p=0.191) 
< GCSE* 29 (31%) 37 (43%) 
GCSE 27 (29%) 18 (21%) 
A levels 11 (12%) 5 (6%) 
Further qualification 27 (29%) 26 (30%) 
Household income (chi-square test: p=0.224) 
< £12 000 15 (16%) 9 (10%) 
£12 000 - £19 999 15 (16%) 26 (30%) 
£20 000 - £29 999 17 (19%) 14 (16%) 
£30 000 - £39 999 9 (10%) 10 (12%) 
> £ 40 000 12 (13%) 13 (15%) 
Retired 23 (25%) 14 (16%) 
*GCSE: General Certificate of Secondary Education 
 
The majority of subjects from both groups had an educational level of GCSE (General 
Certificate of Secondary Education) or lower. Over 40% of the cancer cases and 36% of 
the non-cancer controls completed their A-levels or obtained a further qualification. 
Regarding income, the cancer subjects were most frequently retired (25%) whilst the 
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non-cancer controls were mostly (30%) classified in the band 2 income category (£12 
000–£19 999).   
Among the cancer cases, the average duration from diagnosis of cancer was 24.2 
months. Breast cancer (27%) and gastro-intestinal cancer (23%) were the most common 
tumour sites and the majority of the patients were having chemotherapy (59%) as their 
conventional treatment (Table 3.2).  
Forty three per cent of the cancer cases and 42% of the controls had some form of 
reported chronic disease, with hypertension being the most prevalent in both groups (at 
13 and 15% respectively). There were no significant differences between the two groups 
(p>0.05). 
Table 3.2: Description of the cancer cases and non-cancer controls in terms of the presence of     
disease 
Variable Cancer Cases (n=98)  
Number (%) 
Non-cancer Controls (n=92)  
Number (%) 
Cancer site  
Breast 26 (27%) N/A 
Gastrointestinal 23 (23%) N/A 
Lung 9 (9%) N/A 
Haematological 14 (14%) N/A 
Gynaecological 7 (7%) N/A 
Other 19 (19%) N/A 
Conventional Therapy *   
Radiotherapy 20 (20%) N/A 
Chemotherapy 58 (59%) N/A 
Hormonal therapy 9 (9%) N/A 
Surgery 16 (16%) N/A 
No active treatment 26 (27%) N/A 
Chronic diseases (chi-square test: p=0.488) 
Diabetes 5 (5%) 5 (5%) 
Heart disease 6 (6%) 1 (1%) 
Hypertension 13 (13%) 14 (15%) 
Gout/Arthritis 8 (8%) 4 (4%) 
Asthma 3 (3%) 9 (10%) 
Other 8 (8%) 6 (7%) 
*Total percentage exceeds 100% as some patients chose more than one type of conventional therapy. 
* *N/A: Not applicable 
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3.3  The Most Common CAM Therapies Used by Cancer Subjects and Non-cancer 
Controls 
Forty-six (47%) of the cancer cases and 52 (53%) of the non-cancer controls reported to 
use some form of CAM therapies with no significant statistical difference in CAM use 
between the two groups (p=0.673).  Figure 3.1 illustrates the ten most prevalent forms of 
CAM use among both groups.  
Ten most frequently used CAM types in either the cancer or control 
group
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Figure 3.1: Prevalence of dietary related complementary and alternative medicine (CAM) use  
 
The three most common forms of CAM used among the cancer subjects were large 
quantities of fruit and vegetables/juice (22%), multivitamins (19%) and fish oils (12%) 
(Table 3.2). In the non-cancer controls, the three most common forms of CAM used 
were fish oils (23%), multivitamins (22%) and glucosamine (20%). The prevalence of fish 
oil supplement use among the non-cancer controls was significantly higher than that of 
the cancer cases (p=0.045 with the Chi-square test). Other CAM therapies that were 
more commonly used included green tea, Echinacea, glucosamine and fish oils. Fifteen 
per cent of the cancer cases and 9% of the non-cancer controls reported to have used 
green tea in the past, while 9% of both groups reported to have used Echinacea. Ten 
per cent of the study population in both groups avoided dairy products.   
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 With the exception of fish oil (see above), prescribed sip feeds (p=0.028), beta carotene 
(p=0.021) and selenium (p=0.004), there were no significant differences in the use of 
individual CAM products between the two groups (Table 3.3).  Sip feeds, beta carotene 
and selenium were used to a greater extent by cancer subjects to supplement their oral 
intake.   
 
Thirty one per cent of cancer patients reported to have used some form of micronutrients 
in the past in comparison to 41% of the non-cancer controls with no statistical difference 
between the two groups (p=0.149). The most common single vitamin supplement used 
was vitamin C (11% of cancer patients and 17% of controls respectively) whereas 
calcium was the most common mineral supplement used (6% of cancer patients and 
10% controls). None of these differences were significant (p>0.05). Selenium 
supplements were only used by the cancer patients (6%) with a significant statistical 
difference between the two groups (p=0.004). Alternative medical systems such as the 
Gerson diet or macrobiotic diet, were not used by either group. Other forms of CAM that 
were never used by the cancer cases or the non-cancer controls, included shark 
cartilage and mistletoe.  Only 20% of the cancer cases and 16% of the non-cancer 
controls stated the dose of the supplements taken by them.  Due to insufficient numbers 
that have answered this question, the data could not be analysed further. 
 
To determine whether the presence of chronic diseases influenced the use of CAM in 
the non-cancer control group, they were split into two further groups, one group with 
chronic diseases (n=34) and the other without any chronic diseases (n=57). There was 
still no significant difference in the use of CAM between any of the groups in comparison 
to the cancer cases (p=0.231 and 0.873 respectively) as determined with the chi-square 
test (p=0.231 and 0.873 respectively).  
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Table 3.3: Prevalence of dietary related complementary and alternative medicine (CAM) use 
Type of CAM Cancer cases 
(n=97) 
Number (%) 
Non-cancer 
controls (n=91) 
Number (%) 
p-value 
Multivitamins 18 (19%) 20 (22%) 0.534 
Large quantities of fruit and vegetables / juice 21 (22%) 13 (14%) 0.188 
Fish Oil 12 (12%) 21 (23%) 0.045 
Glucosamine 10 (10%) 18 (20%) 0.058 
Vitamin C 11 (11%) 15 (17%) 0.280 
Green tea 15 (15%) 8 (9%) 0.159 
Avoidance of dairy products 10 (10%) 9 (10%) 0.943 
Echinacea 9 (9%) 8 (9%) 0.925 
Calcium 6 (6%) 9 (10%) 0.338 
Selenium 6 (6%) 0 (0%) 0.004 
Garlic 5 (5%) 7 (8%) 0.453 
Avoidance of meat 7 (7%) 5 (5%) 0.615 
Multivitamins and mineral complex 5 (5%) 5 (6%) 0.903 
Vitamin B complex 7 (7%) 3 (3%) 0.231 
Other 4 (4%) 5 (6%) 0.695 
Vitamin E 7 (7%) 2 (2%) 0.103 
Zinc 5 (5%) 3 (3%) 0.526 
Use of prescribed sipfeeds 7 (7%) 1 (1%) 0.028 
Flaxseed 2 (2%) 3 (3%) 0.582 
Other (micronutrients) 4 (4%) 1 (1%) 0.185 
Ginko Biloba 2 (2%) 3 (3%) 0.582 
Beta Carotene 4 (4%) 0 (0%) 0.021 
Milk Thistle 1 (1%) 2 (2%) 0.508 
St Johns Wort 1 (1%) 1 (1%) 0.952 
Bristol diet 1 (1%) 0 (0%) 0.251 
Spirulina 1 (1%) 0 (0%) 0.253 
Vitamin A 1 (1%) 0 (0%) 0.249 
Ginseng 0 (0%) 1 (1%) 0.224 
Lycopene 0 (0%) 1 (1%) 0.226 
Gerson diet 0 (0%) 0 (0%) N/A 
Macrobiotic diet 0 (0%) 0 (0%) N/A 
Shark Cartilage 0 (0%) 0 (0%) N/A 
Mistletoe 0 (0%) 0 (0%) N/A 
 
Fifty-nine per cent (n=20) of the controls with chronic diseases used CAM, whilst 46% 
(n=26) of the controls without chronic diseases reported to use CAM (Figure 3.2). 
Although the non-cancer controls with chronic disease had a moderately higher use of 
CAM in comparison to the cancer cases, there was no statistically significant difference 
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(p=0.231) between these two groups. There was also no significant difference in the use 
of CAM between the cancer cases and non-cancer controls without any chronic 
diseases (p=0.873).  Chi-square tests were used to calculate the significance of these 
differences. 
 
Figure 3.2:  Comparison in complementary and alternative medicine (CAM) use between cancer cases and non-cancer   
  controls 
 
 3.4  Sociodemographic and Disease Characteristics Associated with CAM  
The Mann-Whitney test was used to determine the association between CAM use and 
characteristics of cancer subjects. Longer duration since diagnosis of cancer (p=0.050), 
and breast cancer (p=0.036) were significantly associated with CAM use (Table 3.4).  
CAM use in cancer subjects was not significantly associated with age, income, level of 
education, gender, marital status, cancer treatment or the presence of chronic disease.   
Similarly, CAM use in the non-cancer controls was also not significantly associated with 
any of the sociodemographic or disease characteristics (p>0.05). In the latter group 
(non-cancer controls) however, there was a trend of increasing CAM use with increasing 
educational level (p=0.08). 
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Table 3.4:  Sociodemographic and disease characteristics associated with complementary and 
alternative (CAM) use in cancer patients and non-cancer controls 
Cancer subjects Non-Cancer controls 
 
Variable 
F-value
M-L 
Chi-
square
P-
value 
 
F-value 
M-L 
Chi-
square 
P-
value 
Age 0.482 - 0.827 0.047 - 0.829 
Level of Income 1.723 - 0.193 0.239 - 0.627 
Level of Education 2.098 - 0.151 3.147 - 0.080 
Duration since diagnosis 3.936 - 0.050 - - N/A 
Gender 
(Male vs female) 
 
- 0.536 0.464 
 
- 0.748 0.387 
Marital Status 
(Single vs Married/Living with a 
partner vs Widowed vs  
Divorced) 
 
 
- 
 
 
0.395 0.941 
 
 
- 2.969 0.397 
Cancer site 
Breast 
Bowel 
Lung 
Non-hodgkins lymphoma 
Leukaemia 
Colon 
Bone 
Other 
- 45.279 0.036 
 
 
 
 
- - - 
Cancer treatment (Yes vs no) 
Chemotherapy 
No active treatment  
Radiotherapy  
Surgery to remove cancer 
Hormonal treatment  
- 
 
0.102 
1.030 
0.059 
0.072 
0.295 
 
0.749 
0.310 
0.807 
0.789 
0.587 
 
 
 
- - - 
Presence of additional chronic 
diseases (yes vs no) 
Diabetes  
Heart disease  
Hypertension 
Gout 
Asthma 
Other 
 
 
- 
 
1.216 
 
 
 
 
 
 
 
0.270 
0.191 
0.896 
0.618 
0.174 
0.495 
0.555 
 
 
- 
 
1.493 
 
 
 
 
 
 
 
0.222 
0.626 
0.241 
0.225 
0.982 
0.699 
0.503 
* M-L: Maximum likelihood 
 
3.5 Communication with Health Professionals 
Of the 46 cancer subjects who reported the use of CAM therapies, only 25 (54%) 
communicated its use to a health professional (Table 3.5). Even fewer patients from the 
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control group communicated this to a health professional, namely 23 (44%) of the 52 
patients in this group. 
 
Table 3.5 Disclosure of complementary and alternative medicine (CAM) use to  
health professionals  
Health professional 
informed of CAM use 
Cancer patients 
(n=25) 
Number (%) 
Non-cancer controls 
(n=23) 
Number (%) 
p-value 
Consultant 16 (62%) 6 (26%) 0.116 
GP 14 (56%) 14 (61% 0.732 
Nurse 9 (36%) 1 (4%) 0.004 
Dietitian 2 (8%) 0 (0%) 0.101 
Pharmacist 2 (8%) 2 (9%) 0.931 
Other 0 (0%) 1 (4%) 0.222 
 
Table 3.4 indicates that the health professionals who were most frequently informed of 
CAM use by their patients were consultants and GPs in both groups. With the exception 
of nurses, there were no significant differences between the two groups. The cancer 
cases (36%) in this study also tended to inform a nurse of their CAM use significantly 
more often than the non-cancer controls (4%) with a p-value of 0.004. 
 
3.6 Main Reasons for Using CAM 
The majority of subjects from both groups used CAM therapies to boost their immune 
systems (cancer patients 49%, non-cancer controls 37%) and to improve their quality of 
life (cancer patients 34%, non-cancer controls 41%) (Table 3.6). Interestingly, 
significantly more patients from the non-cancer control groups (31%) used CAM 
therapies to help with pain relief as opposed to the cancer patients (12%) with a p-value 
of 0.040 (Chi-square test). None of the other differences were significant.  
 
 
 
 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
 - 33 -
Table 3.6: Main reasons for using complementary and alternative medicine (CAM) 
Reasons for using 
CAM 
Cancer patients 
(n=41) 
Number (%) 
Non-cancer Controls 
(n=39) 
Number (%) 
p-value 
To boost immune system 20 (49%) 14 (37%) 0.283 
To improve quality of life 14 (34%) 16 (41%) 0.525 
To help with pain relief 5 (12%) 12 (31%) 0.040 
Other 6 (15%) 9 (23%) 0.333 
To help with stress relief 1 (2%) 2 (5%) 0.524 
 
3.7 Reported Side Effects Associated with CAM Use 
Only 2 (5%) of the cancer subjects reported to have experienced side effects from using 
CAM therapies, and in both cases it was reported to be diarrhoea. It was not possible to 
state which CAM therapy caused the diarrhoea, as subjects used a range of different 
therapies. There were no subjects among the non-cancer controls that reported any side 
effects from these therapies, and there was no significant difference between the two 
groups (p=0.106).  
 
The majority of subjects in both groups reported no change in weight whilst they were 
using CAM therapies (Figure 3.3). However, the non-cancer controls (n=39, 91%) 
exceeded the cancer cases (n=22, 56%) significantly in terms of weight maintenance 
whilst using CAM (Chi-square test; p<0.001). Thirteen per cent (n=5) of the cancer 
cases and 7% (n=3) of the non-cancer controls reported to have lost weight whilst using 
CAM therapies. A further 8% (n=3) and 2% (n=1) of the cancer cases and controls 
respectively reported to have gained weight whilst using these therapies.  
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Figure 3.3: Reported impact of complementary and alternative medicine (CAM) use on weight 
 
3.8 Reported Benefits Associated with CAM Use 
Overall, the non-cancer controls (n=28; 78%) reported significantly more (p=0.017) 
benefits as a result of CAM use as compared to the cancer cases (n=19; 51%). In terms 
of specific benefits (Table 3.7), the cancer cases (47%) reported experiencing optimism 
as a result of using CAM therapies significantly more often (Chi-square test; p=0.044 
compared to the non-cancer controls (20%). There were no other significant differences 
between the two groups. 
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Table 3.7:  Reported benefits associated with complementary and alternative medicine  
(CAM) use  
Reported benefits Cancer patients 
(n=19) 
Number (%) 
Non-cancer Controls 
(n=30) 
Number (%) 
p-value 
Increased optimism 9 (47%) 6 (20%) 0.044 
Increased hope 6 (32%) 3 (10%) 0.090 
Pain relief 2 (11%) 8 (27%) 0.157 
Helped with stress relief 1 (5%) 5 (17%) 0.211 
Helped with side effects of 
cancer treatments 
2 (5%) N/A N/A 
Cured the cancer 0 (0%) N/A N/A 
Other  6 (32%) 13 (42%) 0.461 
*percentages exceed 100%, as participants were allowed to choose more than one option 
 
Nineteen participants reported other benefits from CAM use not specified on the 
questionnaire. These benefits included increased well-being (8% of non-cancer 
controls), less pain in joints (4% of non-cancer controls), improved immunity (4% of non-
cancer controls), less frequent episodes of cystitis (2% of non-cancer controls), reduced 
eczema (2% of non-cancer controls), healthier hair (2% of non-cancer controls), faster 
recovery from colds (2% of non-cancer controls) and increased libido (2% of non-cancer 
controls). Not all participants, especially the cancer cases, specified which other benefits 
they experienced. 
 
3.9 Satisfaction with CAM Use 
Thirty-nine cancer participants answered the question whether they were satisfied with 
the CAM therapies they used. Thirty-five of them (90%) reported to be satisfied with it. 
Similarly, 37 participants among the non-cancer controls answered the above question, 
and 35 (95%) reported to be satisfied with the CAM therapies they used. There were no 
statistical difference between the two groups (p=0.428, Chi-square test).   
 
3.10 Initial Informant of CAM  
Participants were asked who initially informed or encouraged them to use CAM 
therapies (Table 3.8). The majority of participants in both groups initiated the use of 
CAM therapies themselves, with a total of 60% in the cancer group and 46% in the 
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control group. Forty-one per cent of the non-cancer controls were encouraged by their 
friends or family to try CAM therapies, which was significantly more than just 20% of 
cancer cases (p=0.041, Chi-square test). With the exception of the latter group of 
informants, there were no significant differences between the two groups. 
 
Table 3.8: Initial informant of Complementary and Alternative Medicine (CAM) 
  
Source of 
recommendation 
Cancer cases 
(n=41) 
Number (%) 
Non-cancer 
controls (n=39) 
Number (%) 
p-value 
Nurse  0 (0%) 1 (3%) 0.228 
General Practitioner 1 (2%) 4 (10%) 0.137 
Dietitian 2 (5%) 0 (0%) 0.099 
Alternative Therapist 5 (13%) 7 (18%) 0.499 
Friends/Family 8 (20%) 16 (41%) 0.041 
Self 24 (60%) 18 (46%) 0.217 
 
3.11 Reference used for further information on CAM therapies 
Participants were asked how they obtained further information on CAM therapies, once 
they had been informed or encouraged to use it. Most cancer subjects obtained their 
information on CAM use from the media (29%), NHS health professionals (25%) and 
from their friends and family (24%) (Table 3.9). Although the majority of the non-cancer 
controls also obtained their information from their friends and family (44%) they did so 
statistically significantly more often than the cancer cases (p=0.030). The media was 
also a popular source of information among the non-cancer controls (33%). NHS health 
professionals did not feature as prominent in this group (7%), with a statistically 
significant difference (p=0.034) between the two groups as per chi-square test. There 
were no other significant differences between the two groups. 
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Table 3.9: Reference used to obtain further information on complementary and alternative 
medicine (CAM) 
 
Source of information Cancer cases 
(n=40) 
Number (%) 
Non-cancer 
Controls (n=39) 
Number (%) 
p-value 
Media 12 (29%) 13 (33%) 0.695 
NHS Health professional 10 (25%) 3 (7%) 0.034 
Friends/Family 10 (24%) 17 (44%) 0.030 
Internet 4 (10%) 4 (10%) 0.970 
Other 4 (10%) 6 (15%) 0.446 
Alternative health practitioner 3 (8%) 2 (5%) 0.664 
Neighbours 2 (5%) 1 (3%) 0.582 
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CHAPTER 4: DISCUSSION 
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4.1 Introduction 
Cancer patients have been documented to use complementary and alternative 
medicine (CAM) frequently, but the usage rate varies widely between countries and is 
based on varying definitions of CAM.1, 2, 25 However, the use of CAM is increasing 
worldwide, and it is important for the health professional working in oncology to be 
aware of the types of CAM most commonly used in their area, to enable the giving of 
sound advice in a patient-centred environment.  There is a lack in the current literature 
of controlled studies that investigate the prevalence of CAM use among cancer 
patients. To the best of our knowledge there is only one such study where the use of 
CAM in cancer survivors was compared with a non-cancer population.30  According to 
their findings CAM use was modestly higher among cancer survivors (40%) compared 
to the general population (36%).   
 
4.2  Discussion of the Results 
4.2.1 Comparison of CAM use between cancer cases and non-cancer controls 
Our results indicated that there was no significant difference in the overall use of CAM 
between cancer patients and the non-cancer population, with the non-cancer controls 
having a marginally higher use (52%) of CAM than the cancer patients (47%). This 
may have important implications, and shows that an increased awareness and 
knowledge of CAM use should not be limited to those working with oncology patients 
only, but be extended to health professionals in all patient groups.  Our findings are in 
contrast with those of Mao et al.30 who found that CAM use was modestly higher 
among cancer survivors (40%) compared to the general population (36%). However, 
when the non-cancer controls were split into two groups, (one group with chronic 
diseases and one group without any chronic diseases), the prevalence of CAM use 
among cancer patients (47%) and non-cancer controls without any chronic diseases 
(46%) were virtually the same, whereas the non-cancer control group with chronic 
diseases (59%), were moderately higher, although this was not a statistically 
significant difference. This suggests that the presence of a chronic disease (apart from 
cancer) may be associated with a modest increase in CAM use.   
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Looking at the cancer arm of our study population specifically, the prevalence of CAM 
use (47%) was higher than reported by Downer et al. in 1994 who found that 16% of 
cancer patients surveyed in two hospitals in London admitted to using CAM.9 Our 
findings were also higher than a recent survey in the UK (2005), which reported that 
29% of their sampled cancer population was using some form of CAM.32 However, 
research has shown that there has been an increase in CAM use among cancer 
patients in recent years.6 Possible explanations may include an increased awareness 
of CAM therapies among cancer patients, as well as an increased availability of these 
therapies, especially over the counter remedies and supplements. Our results were 
similar to the findings of Chrystel et al. (2003) who found that 49% of cancer patients in 
a New Zealand based cancer centre used CAM.27 It was also consistent with the 
reported 49% CAM use among colorectal cancer patients in a Canadian based cancer 
centre in 2002, as well as the findings of Harris et al. (2003) who reported that 49.6% 
of oncology patients had used at least one type of CAM in the previous 12 months at 
the time the study was conducted.11,25  Our findings were within Ernest and Cassileth’s 
(1998) reported range of 7–64%, based on the results of a systematic review of 21 
studies among cancer patients across 13 countries, but higher than their average of 
31%.6 Clearly there are inconsistencies in the literature with regards to the prevalence 
of CAM use among cancer patients, which may be attributed to varying definitions of 
CAM as well as differences in sample selections and instruments used, which limit a 
direct comparison between these findings.   
It therefore appears that CAM use is increasing in the cancer population, as well as in 
the general population, especially among those with chronic diseases.  This may have 
important implications for health professionals in all patient groups, but especially for 
those working with cancer patients or patients with other chronic diseases, as certain 
CAM may interfere with conventional treatment or have undesirable side-effects. 
4.2.2  The most popular CAM therapies used among both the cancer cases and 
non-cancer contols 
In terms of the most popular CAM therapies used among both groups, our results 
indicated that the preferred therapies were very similar in both groups. Large quantities 
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of juice, multivitamins and fish oils were the three most popular CAM therapies used 
among the cancer cases, while fish oils, multivitamins and glucosamine were the three 
most popular CAM therapies used among the non-cancer controls. Interestingly, the 
prevalence of fish oil supplements among the non-cancer controls was significantly 
higher than that of the cancer cases, even though fish oils, especially omega-3 fatty 
acids are often advocated for use in cancer patients. Omega-3 fatty acids and fish oil 
have been shown to lower the levels of pro-inflammatory cytokines in healthy volunteers 
and in patients with pancreatic cancer.33  A fairly recent study has also shown that a fish 
oil enriched nutritional supplement providing eicosapentaenoic acid (EPA) at 2g per day 
in combination with protein/energy supplementation can reverse the normal pattern of 
ongoing weight loss seen in pancreatic cancer patients.33 On the other hand, fish oil may 
be better known for its use for other clinical conditions such as rheumatoid arthritis and 
hypertriglyceridemia, 34 and may account for the higher use of fish oils in the non-cancer 
control group.  
 
Although the use of selenium and β-carotene was low in the cancer group, it was used 
significantly more than the non-cancer controls.  Previous studies have shown that 
selenium supplementation during chemotherapy offered significant protection from 
nephrotoxicity induced by the chemotherapy agent, cisplatin.35 It was also associated 
with less leucopenia and the need for blood transfusions.  β-carotene has been shown 
to enhance the cytotoxicity of some chemotherapy agents on human squamous 
carcinoma cells.354  These positive effects might explain the higher use of selenium and 
β-carotene in the cancer group. Of concern, however, is the findings of an increased risk 
of lung cancer associated with supplementation with β-carotene mentioned previously.21 
 
The use of micronutrient supplementation proved to be popular in both groups, with 
approximately a third (31%) of cancer patients and 41% of the non-cancer controls 
reported to have used such supplementation at some stage. This was lower than the 
48% reported rate by Tough et al. (2002) among Canadian colorectal patients and much 
lower than the 82.5% reported rate among American cancer patients by Bernstein and 
Grasso in 2001.25, 28 Although the use of micronutrients was fairly high among our British 
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sample, it appears to be lower than those in the United States and Canada.  The doses 
of the supplements used in our study were not known by the majority of patients, which 
is of particular concern, as high doses of certain supplements may be toxic.  Vitamin A 
for example can cause acute symptoms such as nausea and vomiting, increased 
cerebrospinal fluid pressure, muscular incoordination and blurred vision at toxic doses, 
which in the long-term, can lead to reduced bone mineral density and hepatic 
dysfunction. Patients with severe protein malnutrition and pre-existing liver disease, both 
of which are prevalent among oncology patients, are more susceptible to the adverse 
effects of excess Vitamin A.36 Further research is therefore needed to determine the 
typical dose of supplements used by cancer patients.  
 
Alternative diets and therapies that claim to cure cancer such as the Gerson diet, 
Macrobiotic diet, and shark cartilage, were not used by any of the cancer patients or 
controls in this study population. This can perhaps be explained by the fact that only 
patients from a conventional treatment cancer centre who were under direct medical 
treatment was included in this study. The use of alternative therapies in the general 
cancer population might therefore be higher as indicated by this study.  This may 
account for our general finding that non-cancer controls had a higher CAM use than the 
cancer cases, although according to an estimate by McGinnis (1990) only a small 
minority (5%) of cancer patients rejects conventional medicine completely and goes their 
own way.37  However, as by far the majority of previous CAM related studies in cancer 
patients only included samples from conventional treatment centres and hospitals, it 
highlights the need for further research which would include samples from non-
conventional cancer centres, i.e. waiting rooms of alternative health practitioners or 
cancer centres such as the Bristol Cancer Centre.  This will provide more accurate 
information on the prevalence of CAM use in the cancer population as a whole.  
 
4.2.3 Predictors of CAM use 
Many studies have looked at the predictors of CAM use and found younger age, female 
sex, and higher education positively associated with greater CAM use.3, 4, 11, 22, 38  In this 
study time since diagnosis of cancer, and cancer site, were the only significant 
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demographic variables associated with CAM use. Level of education had a borderline 
significant association (p=0.080) with CAM use among the non-cancer controls only. 
4.2.4 Disclosure of CAM use to health professionals 
Only 54% of participants disclosed the use of CAM to health professionals. This is 
consistent with previous studies which found that just about half of the cancer patients 
who used CAM inform their doctors of such use.7, 23, 27 This lack of communication 
between patients and health professionals may limit the opportunity to discuss the 
potential benefits and risks of CAM use, which may otherwise enable them to make 
more informed choices. Although disclosure of CAM use to dietitians was low in 
particular, they may, as the recognised experts in diet and nutrition, play an important 
role in providing safe advice on these therapies. In fact, a number of dietitians already 
practice CAM, while others have established relationships with CAM practitioners.39 
Many CAM therapies are safe and may alleviate symptoms associated with cancer or 
increase patient well-being, on the other hand there are other therapies that may 
interfere with conventional treatments or have serious side effects.  To include direct 
questioning about CAM use as part of history taking has been shown to significantly 
increase disclosure of the use of these therapies to the oncologist.40 Health 
professionals working with cancer patients should therefore be encouraged to routinely 
question patients regarding CAM use, to promote appropriate discussion of these 
therapies.   
 
4.2.5 Reasons for using CAM therapies 
The majority in both groups used CAM therapies to boost their immune systems and to 
improve their quality of life. Megavitamin supplements are one example of CAM 
therapies used to boost the immune system.  In fact, research has shown that Vitamins 
A, C, E and β-carotene at high doses stimulate humoral and cellular immunity.41  Two 
large nutrition intervention trials conducted in China between 1985 -1991 showed a 
correlation between dietary supplementation of specific vitamins and minerals and a 
reduction of the mortality and incidence from human cancer, as well as mortality and 
prevalence from some other commonly seen diseases.42 High doses of vitamin 
supplementation and diet modification in combination with conventional 
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radiotherapy/chemotherapy, may also increase tumor response and improve quality of 
life by decreasing the toxicity of conventional treatment.43    
In terms of CAM therapies used to relieve pain, cancer patients used such therapies 
significantly less than the non-cancer controls. One possible reason may be that CAM 
therapies intended for pain relieve for other chronic diseases such as gout or arthritis 
may be more commonly recognized and utilized. A recent study (2007) has shown that 
glucosamine sulfate caused significant improvement in functional status and pain in 
patients with osteoarthritis, and is well tolerated.44  Another possible explanation for the 
lower prevalence of CAM therapies for pain relief in the cancer cases may be that 
cancer patients’ pain is usually well controlled with analgesia, which may forfeit the need 
for additional remedies.    
 
4.2.6 Benefits associated with CAM use 
Benefits that were reported among the cancer cases as a result of using CAM 
therapies included increased optimism (47%) and increased hope (32%). Downer et al. 
found that hope was the main area of dissatisfaction for the cancer patients in their 
study population.9 This may have important implications for this patient group, as hope 
appears to be a positive coping strategy which may in turn increase optimism and 
quality of life. If patients are not encouraged to maintain hope by health professionals, 
they may seek it from alternative practitioners. It is therefore important for health 
professionals to address this issue when dealing with cancer patients. This may result 
in higher levels of satisfaction with conventional care. 
 
4.2.7 Side effects associated with CAM use 
Our results indicated that only a small minority of patients experienced side effects as 
a result of using CAM therapies. Five per cent of the cancer cases reported having 
experienced diarrhoea and none of the non-cancer controls reported any side effects. 
This is consistent with the findings of Chrystal et al., who found that 91% of their study 
population was not aware of any side effects from CAM therapies.27 Gupta et al. 
(2002) found a slightly higher rate (13%) of minor side effects as a result of CAM use, 
which included nausea, vomiting, rash and diarrhoea.45  Although concerns about side 
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effects from CAM therapies are often cited in the literature, it appears that it has been 
reported in only a small minority of patients in previous studies. However, many 
studies did not ask participants about side effects as a result of their CAM use.  
Furthermore, patients may not always be aware of the side-effects associated with 
CAM, as it may be masked by die disease process or the side-effects of conventional 
treatments.  The prevalence of side-effects may therefore be higher as indicated by 
this study and previous literature, which highlights the need for additional research. 
 
4.2.8 Satisfaction with CAM use 
Satisfaction with CAM therapies was high in both groups, with 90% satisfaction rate 
among the cancer cases, and 95% among the non-cancer controls.  Our findings were 
consistent with that of Downer et al. (1994), 9 who found that 82% of patients were 
either satisfied or very satisfied with the therapies they have chosen. The results of our 
study was higher than those of Begbie et al. (1996) 2 who reported that 70% of patients 
in their study were highly satisfied with alternative treatments, while dissatisfaction was 
almost non-existent (1.4%).  Harris et al. (2003) 11 also found that 72% of patients in 
their study was satisfied with CAM (average for all encounters), 4% were dissatisfied 
and 25% were uncertain. Our results were however much higher than those of Gupta 
et al. (2002),45 who found that only 33% of patients were satisfied with CAM, 57% were 
dissatisfied and 10% were neutral.  The large difference in the latter study may be 
explained by cultural differences, as it was an Indian population survey, where CAM 
therapies mostly comprise of ancient systems of healing that are based on concepts of 
human philosophy. 
 
4.4 Significance of the Study  
This is only the second controlled study that we are aware of that investigates the 
prevalence of CAM use in a cancer population. It is, however, the first controlled study 
that has looked in depth specifically at dietary related CAM use. Our results indicated 
that both the cancer cases and non-cancer controls commonly used CAM, and there 
were no significant differences between the two groups. This shows that an increased 
awareness and knowledge of CAM use should not be limited to those working with 
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oncology patients only, but be extended to health professionals in all patient groups. We 
have shown that disclosure of CAM use to health professionals is low, and patients 
should therefore be asked directly about their use of CAM, to ensure appropriate 
discussion of these therapies. Our results also indicated that the two main benefits 
associated with CAM use were increased optimism and hope, which may be an 
important coping strategy for patients. It is therefore important for health professionals to 
encourage patients to have a positive and hopeful attitude. The provision of certain CAM 
therapies by the NHS in combination with conventional care may be a way forward to 
meet this need. Certainly, we need to have ready access to reliable patient information 
regarding such therapies, which may help patients to make safe and informed decisions 
about their use.  
 
4.5 Limitations 
Several limitations were noted in this study.  
Firstly, it should be noted that this study targeted patients undergoing conventional 
cancer treatment. It does therefore not account for patients who substituted 
conventional care with CAM as their sole treatment. Nevertheless, it does indicate that 
a significant proportion of cancer patients in the Colney Cancer Center use some form 
of CAM therapy, and gives some idea of the current range of therapies.  
 
Secondly, the characteristics of the non-responders are not known, as response to the 
survey was voluntary and anonymous. This may have created a potential selection 
bias if non-responders overrepresented a particular subgroup. The response rate of 
the study was however very good. 
 
Thirdly, in terms of calculating an appropriate sample size for the study, the original 5% 
level of precision at a 95% confidence interval was changed to a 10% level of precision 
on request from the Norfolk Research Ethics Committee. Consequently, the sample 
size was reduced from 321 patients in each group, to 92 patients. The concern was 
raised that the proposed amount of data to be collected may not be needed, and that 
the study could place an unnecessary burden on a fragile oncology group.  
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Fourthly, there are also the limitations typical of a questionnaire used as an instrument, 
which include questions that may be misunderstood, facts wrongly remembered and 
answers deliberately falsified.  
 
Finally, the study did not control for ethnicity which may have introduced a small 
degree of bias.  However, as only 6% of the Norwich population consists of ethnic 
minorities (of which 3% is non-white) it was not considered to have a major impact on 
the results. 
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CHAPTER 5: CONCLUSIONS AND RECOMMENDATIONS 
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5.1 Conclusions 
CAM therapies among cancer patients have been extensively researched in 
uncontrolled studies and their use proven to be high in this patient population. Our study 
has, however, indicated that the prevalence of CAM among cancer patients is no higher 
than that of the general population. This shows that an increased awareness and 
knowledge of CAM use should not be limited to those working with oncology patients 
only, but be extended to health professionals in all patient groups. Disclosure of CAM 
use to health professionals was low in this study, which highlights the importance of 
good communication with cancer patients, including direct questioning of CAM use. 
The main reasons for using CAM therapies in both the cancer patients and non-cancer 
controls were to boost their immune systems and to improve quality of life. Furthermore, 
we found that increased optimism and hope were the two main benefits reported as a 
result from using CAM, and may consequently be an important aid to cope with the 
diagnosis of cancer and the side effects of its conventional treatment. Health 
professionals should therefore encourage patients to maintain a positive and hopeful 
attitude throughout their cancer journey.  Furthermore is it important to help patients 
identify those CAM therapies that are likely to benefit them, and to provide greater 
access to these in the NHS. We also need to have ready access to reliable patient 
information regarding such therapies, which may help patients to make safe and 
informed decisions about their cancer care. 
Health professionals should also establish good communication and encourage a 
positive and hopeful attitude in cancer patients, which may result in higher levels of 
satisfaction with conventional care.    
 
5.2 Recommendations 
In light of the findings of this study, we would suggest the following recommendations: 
1. Further research is needed on CAM use that includes samples from non-
conventional cancer centres i.e. complementary or alternative health care 
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centres to ensure a more accurate reflection of CAM use in the general cancer 
population. 
2. Side effects of CAM use should be more extensively researched, in order for 
health professionals to give safe advice on the use of these therapies.  
3. Further research is also needed on the frequency and dose of supplements 
taken, to ensure the safe use of CAM therapies.  
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Addendum 1 
 
 
 
PATIENT INFORMATION SHEET 
(COLNEY CENTRE) 
 STUDY TITLE:  
Prevalence and usefulness of dietary related complementary and alternative therapies 
among cancer patients. 
 
REFERENCE NUMBER: 2005DIET01S 
You are being invited to take part in a research study. Before you decide to take part 
in the study it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully.  Talk 
to others about the study if you wish. 
 
• Part 1 tells you the purpose of this study and what will happen if you take part.
• Part 2 gives you more detailed information about the conduct of the study. 
 
Ask us if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part. 
PART 1  
 What is the purpose of the study? 
The purpose of the study is to find out how many patients with cancer make use of 
dietary related therapies (other than the conventional medical treatments) to help 
with their cancer.  We would also like to know if cancer patients are more likely to 
use such therapies than the general healthy population.  At present there is not 
enough information available in the United Kingdom to give us a clear picture.  If we 
have a better understanding of the general trend and which dietary therapies are 
more popular to use, it will help health professionals to offer advice to patients who 
wish to discuss or ask about such therapies.  This study forms part  of a  student 
research project which forms part of the study requirements of  a Masters Degree in 
Nutrition 
Why have I been chosen 
We aim to ask every patient with cancer attending the Colney Centre to participate in 
the study until we have recruited 92 patients.  We hope to include 92 patients in the 
Colney Centre and the same number of healthy participants in 3 selected dental 
surgeries. 
 
  Do I have to take part? 
No.  It is up to you if you decide whether or not to take part.  If you do, you will be 
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given this information sheet to keep.  You are still free to withdraw at any time and 
without giving a reason. A decision to withdraw at any time, or a decision not to take 
part, will not affect the standard of care you receive. 
What will happen if I take part? 
The volunteer will offer you a questionnaire to complete.  If you have read all the 
information on the patient information sheet, and decided that you wish to take part, 
you can either complete the questionnaire at the Colney Centre and give it back to a 
volunteer, or put it in the purple box at reception.  If you did not have enough time to 
complete the questionnaire in the Colney Centre today, or you need more time to 
decide whether you want to take part in this study, please feel free to take the 
questionnaire home with you.   A pre-paid envelope is available from reception 
which could be used to return completed questionnaires in. 
The questionnaire may take you approximately 20 – 25 minutes to complete. 
What do I have to do? 
Please complete one questionnaire only and place it in the envelope provided, 
before returning it to us.  Please ask the volunteer for assistance if you require any 
help to complete the questionnaire.  Please do not fill in this questionnaire if you 
already completed this questionnaire before. 
What are the benefits of taking part? 
The study may not benefit you directly, but the information we get might help 
improve the service for patients with cancer. 
 
What if there is a problem? 
Any complaint about the way that you have been dealt with during the study will be 
addressed.  Please contact the researcher (Esmarie van Tonder) on 01603-287 011 
if you wish to discuss any complaints regarding this study. 
Will my taking part in the study be kept confidential? 
Yes.  All the information about your participation in this study will be kept 
confidential.  
 
Is there any thing else that you should know or do? 
The questionnaire includes questions relating to your demographical characteristics, 
i.e. age, gender, income and education level, which will help us to find out whether 
certain characteristics are more closely linked to certain dietary patterns than others. 
If there is one or more question(s) that you are unwilling or feel uncomfortable to 
give an answer to, you may leave that question(s) out.    
 
Contact details of the principal investigator: 
Esmarie van Tonder 
 
ADDRESS:  
Department of Nutrition and Dietetics 
Level 4, Out-patients East 
Norfolk and Norwich University Hospital 
 
CONTACT NUMBER: 01603 287011 
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This completes part 1 of the Information Sheet. If the information in Part 1 has 
interested you and you are considering participation, please continue to read 
the additional information in part 2 before making any decision. 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time. However, once we have received the 
completed questionnaire back from you, it will not be possible to withdraw the 
information provided, from the study. 
 
What if there is a problem? 
If you have a concern about this study, you should ask to speak with the researcher 
who will do her best to answer your questions (Tel: 01603 287 011).  If you remain 
unhappy and wish to complain formally, you can do this through the NHS Complaints 
procedure.  Details can be obtained from the Hospital. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential.  As the questionnaire is anonymous, no one will be able to 
identify you as a person.  The information obtained during the study will be stored 
with the researcher for a period of 5 years.  Only the researcher, the study leader 
and a statistician will have access to the information.  
 
What will happen to the results of the research study? 
The results may be published in a medical journal.  A summary sheet of the results 
will also be made available in the Colney Centre. 
 
Who is organizing and funding the research? 
The researcher will pay for all costs involved in the study. 
 
Who has reviewed this study? 
The study was given a favorable opinion for conduct in the NHS by the Norfolk (1) 
Research Ethics Committee. 
 
Thank you for your consideration to take part in this study, and for taking the time to 
read through this sheet. 
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Addendum 2 
 
Patient Questionnaire (Colney Centre) 
 
Prevalence and Usefulness of Dietary Related Complementary 
and Alternative therapies among cancer patients 
  
1.   What is your age in years? 
 
……………………………………. 
 
2.   Gender  
a) □Male  b) □Female 
 
 
3.   Marital status 
a) □Single   b) □Married /Living with a partner   
c) □Divorced/Seperated        d) □Widowed 
 
 
4.  What is your highest level of education? 
a)□No GCSE or equivalent  b) □GCSE or equivalent   
c) □A levels  d) □ Further qualification 
 
 
5.  What is your household income (per year)? 
a) □Less than £12 000 b) □£12 000 – £19 999 c) □£20 000 – £29 999 
d) □£30 000 – £39 999  e) □>£40 000 f) □ Retired 
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6.  What type of cancer do you have?  
……………………………………………………………………………………………… 
 
 
7. How long ago have you been told that you have cancer?  
……………………………………………………………………………………….. 
 
 
8 i) Do you have any other chronic (long standing) illness at present? 
a)□Yes   b) □No 
 
8 ii) If yes, please indicate which of the following illnesses you have: 
a) □Diabetes  b) □Heart disease 
c) □High blood pressure  d) □Gout/Arthritis  e) □Asthma   
f) □Other (please specify)……………………………………….    
 
 
9. Regarding your medical cancer treatment  
What type of cancer treatment are you currently having (tick all that applies)? 
a) □Radiotherapy   b) □Chemotherapy 
c) □Hormonal therapy  d) □ Operation to remove the cancer 
e) □ No active treatment 
 
10. Prescribed Nutritional Supplements  
Do you currently take any milkshake/fruit juice-style nutritional supplements (e.g. 
Ensure Plus, Enlive Plus, Fortisip, Scandishake, Calogen) to increase the calorie and 
protein content of your diet? 
a)□Yes    b)□No 
 
If your answer is yes, please specify the name(s) of the milkshake/fruit juice style 
supplement you are currently taking 
………………………………………………………………………………… 
 
 
 
 
REGARDING YOUR CURRENT CANCER ILLNESS AND DIETARY HABITS: 
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11.1) Have you used any other dietary therapies or supplements during the past 6 
weeks (other than referred to in question 10)? 
a) □Yes         b) □No   
 
11.2)  If your answer is no, please give your main reason:  
a)□Additional costs 
b) □ Too time consuming to fit it in your daily schedule 
c) □Other (please specify reason) ……………………………………………………… 
12.  Have you as a result of your cancer changed your diet in any of the following 
ways?  
a) Avoidance of meat  Yes□  No□ 
b) Avoidance of dairy products Yes□  No□ 
 
c) Use of high amounts of fruit and vegetable / juices Yes□  No□ 
d) □Other changes to your diet (please specify) 
…………………………………………………………………………………………. 
 
13.  Have you in the past used or are you currently following any of the following 
diets, as a result of your cancer? 
a) Gerson diet  Yes□    No □ 
b) The Macrobiotic diet Yes □   No □   
d) The Bristol diet  Yes □   No □ 
e) □Other (please specify)………………………………………………………. 
 
14.1)  Have you used any vitamin or mineral supplements since your diagnosis of 
cancer? 
a) □Yes    b) □No   
 
14.2) If yes, which of the following vitamin or mineral preparations have you 
used? 
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a) Multivitamins  Yes □  No □  
b) Multivitamin and mineral complex Yes □  No □    
c) Vitamin C    Yes □ No □ Daily Dose ………… 
d) Vitamin E   Yes □ No □ Daily Dose………….. 
e) Vitamin B complex  Yes □ No □ Daily Dose………….. 
f) Vitamin A   Yes □ No □ Daily Dose………….. 
g) Beta Carotene  Yes □ No □ Daily Dose………….. 
h) Lycopene   Yes □ No □  Daily Dose…………… 
i) Calcium   Yes □      No □  Daily Dose.. ………… 
j) Selenium   Yes □ No □ Daily Dose………….. 
k) Zinc   Yes □ No □  Daily Dose………….. 
l) □Other (please specify)…………………………… 
 
15.  Please indicate if you have used any of the following since your diagnosis of 
cancer and indicate for how long: 
a) Green Tea Yes□  No□  Number of years………….. 
b) Grape seed  Yes□  No□  Number of years………….. 
c) Echinacea  Yes□  No□  Number of years………….. 
d) Chaparral   Yes□  No□  Number of years………….. 
e) Flaxseed  Yes□  No□    Number of years…………. 
f) Mistletoe (Iscador) Yes□  No□  Number of years………….. 
g) Shark cartilage Yes□  No□  Number of years………….. 
h) Milk Thistle  Yes□  No□  Number of years………….. 
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i)  Glucosamine Yes□  No□  Number of years………….. 
j)  Fish oil  Yes□  No□  Number of years………….. 
k) Garlic pills  Yes□  No□  Number of years………….. 
l)  Ginko Biloba Yes□  No□  Number of years………….. 
n) Ginseng  Yes□  No□  Number of years…………. 
o) St John’s Wort Yes□  No□  Number of years…………. 
p) Spirulina  Yes□  No□  Number of years………….. 
q) □Other (please specify)…………………………………………………… 
 
Please only complete the rest of the questionnaire if you answered “yes” to 
any of questions 11 - 15 
 
16. Did you find any difference in your weight whilst being on these 
therapies/diets? 
a) □Weight loss  b) □Weight gain  c) □No change in weight 
d) □Not sure 
 
17. Who initially recommended to you to use any of these therapies/diets? 
a)□Consultant Oncologist b) □Nurse specialist  c) □GP 
d) □Dietitian   e) □Alternative therapist  f) □Pharmacist   
g) □Friends/Family h) □Self 
 
18. Where did you obtain information about these therapies? 
a) □NHS Health professional b) □Alternative health practitioner   
c) □Internet   d) □Friends/Family  
e) □Media (Newspaper/Television/Magazine)  f) □Neighbors 
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g) □Other (please specify) …………………………………. 
 
19. What is (or was) your main reason to use these therapies (tick one only)? 
a) □To help with side effects of cancer treatments 
b) □For pain relief   
c) □To boost your immune system 
d) □To improve your quality of life 
e) □To help stress relieve 
f) □Hope it has an anti-cancer effect 
g) □Hope it can cure the cancer 
h) □Other (please specify) ……………………………………………………………… 
 
20.1) Did you inform any health professional that you are using any of these 
complimentary therapies/remedies? 
a) □Yes   b) □No  
If your answer is no, please explain why you did not tell anyone 
…………………………………………………………………………………………. 
 
20.2) If yes, please specify whom you told 
a) Consultant Yes□  No□   
b) GP   Yes□  No□  
c) Specialist Nurse Yes□  No□  
d) Dietitian  Yes□  No□  
e) Pharmacist  Yes□  No□ 
f) □Other (please specify)………………………………………... 
 
21. Did you experience any side effects from the dietary therapies or supplements 
you have used?  
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a) □Yes   b) □No 
 
If your answer is yes, please specify which side effects you experienced: 
 
…………………………………………………………………………………………. 
 
 
22.1 Did you experience any benefits from using dietary therapies/ supplements? 
a) □ Yes    b) □ No 
 
22.2 If your answer is yes, please specify which of the following benefits you experienced: 
a) □Helped with side effects of cancer treatments 
b) □ Pain relief   
c) □ Helped with stress relieve 
d) □Increased your hope  
e) □ It cured the cancer 
f)  □ Increased optimism/positive thinking 
g) □Other (please specify) ……………………………………………………………… 
 
 
23. Were you satisfied with the dietary therapy/supplements that you have used? 
□Yes  □No   
 
If no, please specify why you were not satisfied  
 
……………………………………………………………………………………………… 
Thank you for taking the time to complete the questionnaire.  Please put the 
questionnaire in the box provided at reception. 
 
 
 
Researcher:  
Esmarie van Tonder (Senior Dietitian) 
Department of Nutrition and Dietetics 
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Level 4, East Block 
Norfolk and Norwich University Hospital NHS Trust 
Tel: 01603 287011 
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Addendum 3 
 
 
 
PATIENT INFORMATION SHEET 
(DENTAL SURGERIES) 
 
 STUDY TITLE:  
Prevalence and usefulness of dietary related complementary and alternative therapies 
among cancer patients. 
 
REFERENCE NUMBER: 2005DIET01S 
 
You are being invited to take part in a research study. Before you decide to take part in the 
study it is important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully.  Talk to others about 
the study if you wish. 
 
• Part 1 tells you the purpose of this study and what will happen if you take part. 
• Part 2 gives you more detailed information about the conduct of the study. 
 
Ask us if there is anything that is not clear or if you would like more information.  Take time 
to decide whether or not you wish to take part. 
 
PART 1  
 What is the purpose of the study? 
The purpose of the study is to find out how many patients with cancer make use of dietary 
related therapies (other than the conventional medical treatments) to help against cancer.  
We would also like to know if cancer patients are more likely to use such therapies than the 
general healthy population.  At present there is not enough information available in the 
United Kingdom to give us a clear picture.  If we have a better understanding of the general 
trend and which dietary therapies are more popular to use, it will help health professionals 
to offer advice to patients who wish to discuss or ask about such therapies.  This study 
forms part  of a  student research project which forms part of the study requirements of  a 
Masters Degree in Nutrition 
 
Why have I been chosen 
This dental surgery forms part of the healthy control part of the study.  We aim to ask every 
patient attending this dental surgery during the period of research, to participate in the 
study until we have recruited approximately 31 patients from this dental surgery. 
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  Do I have to take part? 
No.  It is up to you if you decide whether or not to take part.  If you do, you will be given this 
information sheet to keep.  You are still free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive. 
 
What will happen if I take part? 
The receptionist will offer you a questionnaire to complete.  If you have read all the 
information on the patient information sheet, and decided that you wish to take part, you 
can complete the questionnaire at the dental surgery and give it back to the receptionist.  If 
you did not have enough time to complete the questionnaire in the dental surgery today, or 
you need more time to decide whether you want to take part in this study, please feel free 
to take the questionnaire home with you.   A pre-paid envelope is available from reception 
which could be used to return completed questionnaires in. 
The questionnaire may take you approximately 20 – 25 minutes to complete. 
 
What do I have to do? 
Please complete one questionnaire only and place it in the envelope provided, before 
returning it to us.  Please ask the receptionist for assistance if you require any help to 
complete the questionnaire.  Please do not fill in this questionnaire if you have already 
completed this questionnaire before. 
 
What are the benefits of taking part? 
The study may not benefit you directly, but the information we get might help improve the 
service for people with cancer. 
 
What if there is a problem? 
Any complaint about the way that you have been dealt with during the study will be 
addressed.  Please contact the researcher (Esmarie van Tonder) on 01603-287 011 if you 
wish to discuss any complaints regarding this study. 
 
Will my taking part in the study be kept confidential? 
Yes.  All the information about your participation in this study will be kept confidential.  
 
Is there any thing else that you should know or do? 
The questionnaire includes questions relating to your demographical characteristics, i.e. 
age, gender, income and education level, which will help us to find out whether certain 
characteristics are more closely linked to certain dietary patterns than others. If there is one 
or more question(s) that you are unwilling or feel uncomfortable to give an answer to, you 
may leave that question(s) out.    
 
Contact details of the principal investigator: 
Esmarie van Tonder 
 
ADDRESS:  
Department of Nutrition and Dietetics 
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Level 4, Out-patients East 
Norfolk and Norwich University Hospital 
CONTACT NUMBER: 01603 287011 
 
This completes part 1 of the Information Sheet. If the information in Part 1 has 
interested you and you are considering participation, please continue to read the 
additional information in part 2 before making any decision. 
 
PART 2 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time.  However, once we have received the 
completed questionnaire back from you, it will not be possible to withdraw the information 
provided, from the study. 
 
What if there is a problem? 
If you have a concern about this study, you should ask to speak with the researcher who 
will do her best to answer your questions (Tel: 01603 287 011).   
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential.  As the questionnaire is anonymous, no one will be able to identify you 
as a person.  The information obtained during the study will be stored with the researcher 
for a period of 5 years.  Only the researcher, the study leader and a statistician will have 
access to the information.  
 
What will happen to the results of the research study? 
The results may be published in a medical journal.  A summary sheet of the results will be 
made available in the dental surgery. 
 
Who is organizing and funding the research? 
The researcher will pay for all costs involved in the study. 
 
Who has reviewed this study? 
The study was given a favorable opinion for conduct in the NHS by the Norfolk (1) 
Research Ethics Committee. 
 
Thank you for your consideration to take part in this study, and for taking the time to read 
through this sheet. 
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Addendum 4 
 
 
 
Patient Questionnaire (Dental Surgeries) 
 
Prevalence and Usefulness of Dietary Related Complementary 
and Alternative therapies among cancer patients 
  
 
1.   What is your age in years? 
 
……………………………………….. 
 
2.   Gender  
a) □Male  b)□Female 
 
3.   Marital status 
a) □Single  b) □Married /Living with a partner c) □Divorced/Seperated 
d) □Widowed 
 
4.  Highest level of education:  
a)□No GCSE or equivalent  b) □GCSE or equivalent   
c) □A levels  d) □ Further qualification 
 
5.  Household income (per year):   
a) □Less than £12 000 b) □£12 000 – £19 999 c) □£20 000 – £29 999 
d) □£30 000 – £39 999  e) □>£40 000 f) □ Retired 
 
 
6.1) Do you have any chronic (long standing) illness at present? 
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a) □Yes  b) □No 
 
6.2) If yes, please indicate which of the following: 
a) □Diabetes  b) □Heart disease  c) □ High blood pressure 
d) □Gout/Arthritis  e) □Asthma       
f) □Other (please specify)……………………………………….    
 
7. Prescribed Nutritional Supplements  
Do you currently take any milkshake/fruit juice-style nutritional supplements (e.g. 
Ensure Plus, Enlive Plus, Fortisip, Scandishake, Calogen) to increase the calorie and 
protein content of your diet? 
 
a)□Yes    b)□No 
 
If your answer is yes, please specify the name of the milkshake/fruit juice style 
supplement you are currently taking 
………………………………………………………………………………… 
 
 
8.1 Have you used any other dietary therapies or supplements during the past 6 
weeks (other than referred to in question 7)? 
a) □Yes         b) □No   
 
8.2)  If your answer is no, please give your main reason:  
a)□Additional costs 
b) □ Too time consuming to fit it in your daily schedule 
c) □Other (please specify reason) ……………………………………………………… 
 
 
9. Have you in the past or are you at present modifying your diet in any of the 
following ways? 
a) Avoidance of meat □Yes  □No  
b) Avoidance of dairy products □Yes □No 
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c) Use of high amounts of fruit and vegetable juices □Yes □No 
 
d) Other changes to your diet (please specify) 
……………………………………………………………………………………………  
 
10.  Have you in the past used or are you currently following any of the following 
diets? 
a) Gerson diet  Yes□    No □ 
b) The Macrobiotic diet Yes □   No □   
d) The Bristol diet  Yes □   No □ 
e) □Other (please specify)………………………………………………………. 
 
11.1)   Have you ever used any vitamin or mineral supplements for health 
reasons? 
□Yes    □No   
 
11.2)  If yes, which of the following vitamin or mineral preparations have you 
used? 
a) Multivitamins    Yes □  No □  
b) Multivitamin and mineral complex  Yes □  No □    
c) Vitamin C    Yes □  No □ Daily Dose ……… 
d) Vitamin E   Yes □  No □ Daily Dose……… 
e) Vitamin B complex  Yes □  No □ Daily Dose………. 
f) Vitamin A   Yes □  No □ Daily Dose……….. 
g) Beta Carotene  Yes □  No □ Daily Dose………… 
h) Lycopene   Yes □  No □  Daily Dose………… 
i) Calcium   Yes □       No □  Daily Dose..……….. 
j) Selenium   Yes □  No □ Daily Dose………… 
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k) Zinc   Yes □  No □  Daily Dose………… 
l) □Other (please specify)…………………………… 
 
12.  Please indicate if you have used any of the following and indicate for how 
long: 
a) Green Tea Yes□  No□  Number of years………….. 
b) Grape seed  Yes□  No□  Number of years………….. 
c) Echinacea  Yes□  No□  Number of years………….. 
d) Chaparral   Yes□  No□  Number of years………….. 
e) Flaxseed  Yes□  No□    Number of years…………. 
f) Mistletoe (Iscador) Yes□  No□  Number of years………….. 
g) Shark cartilage Yes□  No□  Number of years………….. 
h) Milk Thistle  Yes□  No□  Number of years………….. 
i)  Glucosamine Yes□  No□  Number of years………….. 
j)  Fish oil  Yes□  No□  Number of years………….. 
k) Garlic pills  Yes□  No□  Number of years………….. 
l)  Ginko Biloba Yes□  No□  Number of years………….. 
n) Giseng  Yes□  No□  Number of years…………. 
o) St John’s Wort Yes□  No□  Number of years…………. 
p) Spirulina  Yes□  No□  Number of years………….. 
q) □Other (please specify)…………………………………………………… 
 
 
Please only complete the rest of the questionnaire if you answered 
“yes” to any of questions 8 – 12. 
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13. Did you find any difference in your weight whilst being on these 
therapies/diets? 
a) □Weight loss  b) □Weight gain  c) □No change in weight 
d) □Not sure 
 
14. Who initially recommended to you to use any of these therapies/diets? 
a) □Nurse specialist  b) □GP  c) □Dietitian   d) □Alternative therapist  
e) □Pharmacist f) □Friends/ Family g) □Self 
 
15. Where did you obtain information about these therapies? 
a) □NHS Health professional b) □Alternative health practitioner   
c) □Internet  d) □Friends/Family  
e) □Media (Newspaper/Television/Magazine)  f) □Neighbors 
g) □Other (please specify) …………………………………. 
 
16. What is (or was) your main reason to use these therapies (tick one only)? 
  
a) □To boost your immune system 
b) □To improve your quality of life 
c) □To help stress relieve 
d) □To relieve pain 
e) □ Increased optimism/positive thinking 
f) □Other (please specify) ……………………………………………………………… 
 
17.1) Did you inform any health professional that you are using any of these 
complimentary/alternative therapies? 
a) □Yes   b) □No  
Stellenbosch University http://scholar.sun.ac.za
 - 77 -
If your answer is no, please specify why not 
…………………………………………………………………………………………. 
 
17.2) If yes, please specify whom you told  
a) Consultant Yes□  No□   
b) GP   Yes□  No□  
c) Specialist Nurse Yes□  No□  
d) Dietitian  Yes□  No□  
e) Pharmacist Yes□  No□ 
f) □Other (please specify)………………………………………... 
 
18.1 Did you experience any side effects from the dietary therapies or 
supplements you have used?  
Yes□   No□ 
 
18.2 If your answer is yes, please specify which side effects you experienced: 
 
…………………………………………………………………………………………. 
 
 
 
19.1 Did you experience any benefits from using complimentary therapies? 
 
a) □ Yes    b) □ No 
19.2 If your answer is yes, please specify which of the following benefits you experienced: 
a) □ Pain relief   
b) □ Helped with stress relieve 
c) □Increased your hope  
d)  □ Increased optimism/positive thinking 
e) □Other (please specify) ……………………………………………………………… 
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20. Were you satisfied with the complimentary therapy (home remedy) that you 
have used? 
a) □Yes   b) □No   
 
If no, please specify why you were not satisfied  
 
……………………………………………………………………………………………… 
 
 
Thank you for taking the time to complete the questionnaire.  Please put the 
questionnaire in the envelope provided and hand back to reception. 
 
 
Researcher:  
Esmarie van Tonder (Senior Dietitian) 
Department of Nutrition and Dietetics 
Level 4, East Block 
Norfolk and Norwich University Hospital NHS Trust 
Tel: 01603 287011 
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